Cash & equivalents decreased 58.5%
Cash & equivalents changed -58.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -58.5% from the comparable as-filed period.
Research & development changed -84.1% from the comparable as-filed period.
Capital expenditure changed -74.4% from the comparable as-filed period.
Stock-based compensation changed -85.8% from the comparable as-filed period.
Current assets changed -23.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed -19.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.